Perspective Therapeutics sells 92M shares at 95c in private placement

Perspective Therapeutics announced that it has entered into an investment agreement with a select group of institutional accredited investors, to sell securities in a private placement for aggregate gross proceeds of approximately $87.4M, before deducting placement agent fees and other offering expenses. In the private placement, the company is selling 92,009,981 shares of its common stock at a price of 95c per share, representing the closing price per share of the company’s common stock on the NYSE American as of March 1. The private placement is expected to close on March 6, subject to the satisfaction of customary closing conditions. Oppenheimer & Co. is acting as lead placement agent for the private placement. B. Riley Securities is acting as a placement agent, and JonesTrading Institutional Services and LifeSci Capital are acting as co-placement agents for the private placement.